Inhibition of Influenza Virus Replication by Oseltamivir Derivatives

Characterized by the high morbidity and mortality and seasonal surge, the influenza virus (IV) remains a major public health challenge. Oseltamivir is commonly used as a first-line antiviral. As a neuraminidase inhibitor, it attenuates the penetration of viruses through the mucus on the respiratory...

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Renee W. Y. Chan, Kin P. Tao, Jiqing Ye, Kevin K. Y. Lui, Xiao Yang, Cong Ma, Paul K. S. Chan
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	oseltamivir derivatives influenza virus influenza antiviral oseltamivir-resistant
Online Access:	https://www.mdpi.com/2076-0817/11/2/237